Prometheus
Warszawa, Poland
UPS is a software, automatic fetal congenital heart defect detection system for ultrasound. Using Artificial Intelligence (AI) and machine learning (ML) to analyze ultrasound recordings. It helps with a high probability of more than 90% to determine the likelihood of whether or not a fetal congenital heart defect is present between 18 and 22 weeks of pregnancy.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- prometheusmedtech.ai/
Only accessible to MedStartr community members.
Join nowWhat do you think of Prometheus?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now